Differential effects on somatic and reflex development by chronic clomipramine treatment

Physiology and Behavior

Volumn 82, Issue 2-3, 2004, Pages 375-379

  Lopes De Souza, Sandra ^a   Nogueira, Maria Inês ^a,b   De Jesus Deiró, Tereza Cristina Bomfim ^c   De Castro, Francisco MacHado Manhaes ^c   Da Silva, Cristiano Mendes ^a   Da Silva, Matilde Cesiana ^c   De Lira, Luciene Oliveira ^c   Azmitia, Efrain C ^b   De Castro, Raul Manhaes ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK UNIVERSITY   (United States)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Body growth; Clomipramine; Neonatal rat; Noradrenaline; Reflex ontogeny; Serotonin

Indexed keywords

CLOMIPRAMINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BODY GROWTH; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; HEARING ACUITY; INCISOR; MALE; MATURATION; NEWBORN; NONHUMAN; ONTOGENY; PERINATAL PERIOD; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; RAT; REFLEX; RIGHTING REFLEX; STARTLE REFLEX; TOOTH ERUPTION; VIBRISSA;

EID: 3242766000     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.04.007     Document Type: Article

References (46)

1. Dow-Edwards D.L. Modification of acoustic startle reactivity by cocaine administration during the postnatal period: comparison with a specific serotonin reuptake inhibitor. Neurotoxicol. Teratol. 18(3):1996;289-296
2. Azmitia E.C., Whitaker-Azmitia P.M. Handbook of experimental pharmacology: serotonergic neurons and 5-HT receptors in the CNS. Baumgarten H.G., Gothert M. Development and neuroplasticity of central serotonergic neurons. 1997;1-39
3. Lauder J.M., Krebs H. Serotonin as a differentiation signal in early neurogenesis. Dev. Neurosci. 1(1):1978;15-30
4. Laifenfeld D., Klein E., Ben-Shachar D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J. Neurochem. 83(5):2002;1054-1064
5. Manhaes de Castro R., Cabral Filho J.E., Costa J.A., Costa F.B.R., Gallindo M.A.C., Hecksher C.A. Neonatal treatment with naloxone causes permanent hyperalgesia in rats. Braz. J. Med. Biol. Res. 26:1993;747-751
6. Manhaes de Castro R., Barreto Medeiros J.M., Mendes da Silva C. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor. Braz. J. Med. Biol. Res. 34:2001;121-124
7. Turcotte J.E., Debonnel G., de Montigny C., Hebert C., Blier P. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology. 24(5):2001;511-521
8. Szabo S.T., de Montigny C., Blier P. Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int. J. Neuropsychopharmacol. 3(1):2000;1-11
9. Boscarino B.T., Parfitt D.B. Chronic oral administration of clomipramine decreases sexual behavior in the male Syrian hamster (Mesocricetus auratus). Physiol. Behav. 75:2002;361-366
10. Feenstra M.G., van Galen H., Te Riele P.J., Botterblom M.H., Mirmiran M. Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine. Pharmacol. Biochem. Behav. 55:1996;642-647
11. Manev H., Uz T., Smalheiser N.R., Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 5(1-2):2001;67-70
12. Mendes da Silva C., Souza S.L., Barreto Medeiros J.M., Freitas Silva S.R., Antunes D.E.C., Cunha A.D.U., et al. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swin in adult rats. Arq. Neuropsiquiatr. 60:2002;928-931
13. Fox M.W. Reflex-ontogeny and behavioral development of the mouse. Anim. Behav. 13:1965;234-241
14. Smart J.L., Dobbing J. Vulnerability of developing brain: VI. Relative effects of fetal and early postnatal undernutrition on reflex ontogeny and development of behavior in the rat. Brain Res. 29:1971;303-314
15. Lane R., Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J. Clin. Psychopharmacol. 17:1997;208-221
16. De Boers S., Mirmiran M., Van Haaren F., Louwerse A., Van de Poll N.E. Neurobehavioral teratogenic effects of clomipramine and alphamethyldopa. Neurotoxicol. Teratol. 11(1):1989;77-84
17. Halford J.C.G., Blundell J.E. Pharmacology of appetite suppression. Prog. Drug Res. 54:2000;26-58
18. Vijayakumar M., Metti B.L. Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression. Neurochem. Res. 24:1999;345-349
19. Lauder J.M. Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16:1993;233-240
20. Moiseiwitsch J.R.D., Lauder J.M. Stimulation of murine tooth development in organotypic culture by the neurotransmitter serotonin. Arch. Oral. Biol. 41:1996;161-165
21. Yan W., Wilson C.C., Haring J.H. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate gramile cells. Dev. Brain Res. 98:1997;185-190
22. Byrd K.E., Sheskin T.A. Effects of post-natal serotonin levels on craniofacial complex. J. Dent. Res. 80(8):2001;1730-1735
23. Lauder J.M. Neurotransmitters as morphogens. Biochem. Basis Funct. Neuroteratology. 73:1988;365-387
24. Deiró TCBJ, Barreto Medeiros JM, Souza SL, Freitas Silva SR, De Castro CMMB, Cabral-Filho JE, et al. Neonatal treatment with selective serotonin reuptake inhibitor delays reflex ontogeny and somatic maturation in the rat (manuscript submitted).
25. Ono H., Fukuda H. Pharmacology of descending noradrenergic systems in relation to motor function. Pharmacol. Ther. 68(1):1995;105-112
26. Tanaka H., Takahashi S., Miyamoto A., Oki J., Cho K., Okuno A. Developmental changes in the noradrenergic innervations of spinal motoneurons in neonatal rats. Pediatr. Neurol. 14(1):1996;21-27
27. Ono H., Hasebe Y., Satoh M., Nagao T., Ohta S., Hirobe M., et al. Amphetamine-antagonistic properties of 4-phenyl-1,2,3,4- tetrahydroisoquinoline: inhibition of spinal reflex-enhancing effects of methamphetamine, phenylethylamine and nomifensine. Brain Res. 564(2):1991;319-322
28. Andersen S.L., Dumont N.L., Teicher M.H. Differences in behavior and monoamine laterality following neonatal clomipramine treatment. Dev. Psychobiol. 41:2002;50-57
29. Feng P., Ma Y., Vogel G.W. The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. Brain Res. Dev. Brain Res. 129:2001;107-110
30. Vogel G., Neill D., Kors D., Hagler M. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14:1990;77-83
31. O'Hara M.W. Social support, life events, and depression during pregnancy and the puerperium. Arch. Gen. Psychiatry. 43(6):1986;569-573
32. Suri R., Stowe Z.N., Hendrick V., Hostetter A., Widawski M., Altshuler L.L. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol. Psychiatry. 52(5):2002;446-451
33. Nulman I., Rovet J., Stewart D.E., Wolpin J., Pace-Asciak P., Shuhaiber S., et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry. 159(11):2002;1889-1895
34. Kristensen J.H., Hackett L.P., Kohan R., Paech M., Iiett K.F. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J. Hum. Lact. 18(2):2002;139-143
35. Hendrick V., Burt V.K., Altshuler L.L. Psychotropic guidelines for breast-feeding mothers. Am. J. Psychiatry. 153(9):1996;1236-1237
36. Wisner K.L., Perel J.M., Findling R.L., Hinnes R.L. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol. Bull. 33(2):1997;249-251
37. Chambers C.D., Anderson P.O., Thomas R.G., Dick L.M., Felix R.J., Jonhson K.A., et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics. 104(5):1999;e61
38. Hendrick V., Smith L.M., Hwang S., Altshuler L.L., Haynes D. Weight gain in breastfed infants of mothers taking antidepressant medications. J. Clin. Psychiatry. 64(4):2003;410-412
39. Musa A.B., Smith C.S. Neonatal effects of maternal clomipramine therapy. Arch. Dis. Child. 54(5):1979;405
40. Cowe L., Lloyd D.J., Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br. Med. J. 284(6332):1982;1837-1838
41. Hilakivi L.A., Stenberg D., Sinclair J.D., Kiianmaa K. Neonatal desipramine or zimeldine treatment causes long-lasting changes in brain monoaminergic systems and alcohol related behavior in rats. Psychopharmacology (Berl.). 91(4):1987;403-409
42. Grimm V.E., Frieder B. Prenatal and early postnatal exposure to zimelidine: behavioral, neurochemical and histological findings in rats. Int. J. Neurosci. 33(3-4):1987 (April);225-235
43. Resnick O., Miller M., Forbes W., Hall R., Kemper T., Bronzino J., et al. Developmental protein malnutrition: influences on the central nervous system of the rat. Neurosci. Biobehav. Rev. 3:1979;233-246
44. Nelson C.A., Carver L.J. The effects of stress and trauma on brain and memory: a view from development cognitive neuroscience. Dev. Psychopathol. 10(4):1998;793-809
45. Sundstrom E., Kolare S., Souverbie F., Samuelsson E.B., Pschera H., Lunell N.O., et al. Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res. Dev. Brain Res. 75(1):1993;1-12
46. Loizou L.A., Salt P. Regional changes in monoamines of the rat brain during postnatal development. Brain Res. 20:1970;467-470